Visceral fat is an independent predictor of all-cause mortality in men

Obesity

Volumn 14, Issue 2, 2006, Pages 336-341

  Kuk, Jennifer L ^a   Katzmarzyk, Peter T ^a   Nichaman, Milton Z ^b   Church, Timothy S ^b   Blair, Steven N ^b   Ross, Robert ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b Cooper Institute ^*  (United States)

Author keywords

Abdominal fat; Computed tomography; Liver fat; Waist circumference

Indexed keywords

ABDOMINAL SUBCUTANEOUS FAT; AGED; ARTICLE; BODY COMPOSITION; CAUSE OF DEATH; COMPUTER ASSISTED TOMOGRAPHY; CONFIDENCE INTERVAL; HUMAN; INTRAABDOMINAL FAT; LIVER; MALE; METABOLISM; MIDDLE AGED; MORTALITY; OBESITY; PHYSIOLOGY; PREDICTION AND FORECASTING; RISK; RISK FACTOR; STATISTICAL MODEL; WAIST HIP RATIO;

AGED; BODY COMPOSITION; CAUSE OF DEATH; CONFIDENCE INTERVALS; HUMANS; INTRA-ABDOMINAL FAT; LINEAR MODELS; LIVER; MALE; MIDDLE AGED; OBESITY; ODDS RATIO; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SUBCUTANEOUS FAT, ABDOMINAL; TOMOGRAPHY, X-RAY COMPUTED; WAIST-HIP RATIO;

EID: 33646946281     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2006.43     Document Type: Article

References (35)

1. Okosun IS, Liao Y, Rotimi CN, Prewitt TE, Cooper RS. Abdominal adiposity and clustering of multiple metabolic syndrome in white, black and Hispanic Americans. Ann Epidemiol. 2000;10:263-70.
2. Nicklas BJ, Penninx BW, Cesari M, et al. Association of visceral adipose tissue with incident myocardial infarction in older men and women: the health, aging and body composition study. Am J Epidemiol. 2004; 160:741-9.
3. Janssen I, Katzmarzyk PT, Ross R. Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nutr. 2004;79:379-84.
4. Bigaard J, Tjonneland A, Thomsen BL, Overvad K, Heitmann BL, Sorensen TI. Waist circumference BMI, smoking, and mortality in middle-aged men and women. Obes Res. 2003:11:895-903.
5. Ross R, Leger L, Morris D, de Guise J, Guardo R. Quantification of adipose tissue by MRI: relationship with anthropometric variables. J Appl Physiol. 1992;72:787-95.
6. Despres JP, Moorjani S, Lupien PJ, Tremblay A, Nadeau A, Bouchard C. Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Arteriosclerosis. 1990;10:497-511.
7. Nguyen-Duy TB, Nichaman MZ, Church TS, Blair SN, Ross R. Visceral fat and liver fat are independent predictors of metabolic risk factors in men. Am J Physiol Endocrinol Metab. 2003;284:E1065-71.
8. Banerji MA, Buckley MC, Chaiken RL, Gordon D, Lebovitz HE, Kral JG. Liver fat, serum triglycerides and visceral adipose tissue in insulin-sensitive and insulin-resistant black men with NIDDM. Int J Obes Relat Metab Disord. 1995; 19: 846-50.
9. Despres JP, Lemieux S, Lamarche B, et al. The insulin resistance-dyslipidemic syndrome: contribution of visceral obesity and therapeutic implications. Int J Obes Relat Metab Disord. 1995;19(Suppl 1):S76-86.
10. Ross R, Dagnone D, Jones PJ, et al. Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial. Ann Intern Med. 2000;133:92-103.
11. Boyko EJ, Fujimoto WY, Leonetti DL, Newell-Morris L. Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans. Diabetes Care. 2000;23: 465-71.
12. Tiikkainen M, Tamminen M, Hakkinen AM, et al. Liverfat accumulation and insulin resistance in obese women with previous gestational diabetes. Obes Res. 2002;10:859-67.
13. Marchesini G, Brizi M, Morselli-Labate AM, et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med. 1999;107:450-5.
14. Kelley DE, Thaete FL, Troost F, Huwe T, Goodpaster BH. Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance. Am J Physiol Endocrinol Metab. 2000;278:E941-8.
15. Rich S, McLaughlin VV. Detection of subclinical cardiovascular disease: the emerging role of electron beam computed tomography. Prev Med. 2002;34:1-10.
16. Lee S, Janssen I, Ross R. Interindividual variation in abdominal subcutaneous and visceral adipose tissue: influence of measurement site. J Appl Physiol. 2004;97:948-54.
17. Piekarski J, Goldberg HI, Royal SA, Axel L, Moss AA. Difference between liver and spleen CT numbers in the normal adult: its usefulness in predicting the presence of diffuse liver disease. Radiology. 1980;137:727-9.
18. Ricci C, Longo R, Gioulis E, et al. Noninvasive in vivo quantitative assessment of fat content in human liver. J Hepatol. 1997;27:108-13.
19. Prentice RL, Pyke R. Logistic disease incidence models and case-control studies. Biometrika. 1979;66:403-11.
20. Despres JP, Lamarche B. Effects of diet and physical activity on adiposity and body fat distribution: implications for the prevention of cardiovascular disease. Nutr Res Rev. 1993;6:137-59.
21. Matsuzawa Y, Funahashi T, Nakamura T. Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances. Ann N Y Acad Sci. 1999;892:146-54.
22. Han TS, Seidell JC, Currall JE, Morrison CE, Deurenberg P, Lean ME. The influences of height and age on waist circumference as an index of adiposity in adults. Int J Obes Relat Metab Disord. 1997;21:83-9.
23. Scheen AJ, Luyckx FH. Obesity and liver disease. Best Pract Res Clin Endocrinol Metab. 2002;16:703-16.
24. Yki-Jarvinen H, Westerbacka J. The fatty liver and insulin resistance. Curr Mol Med. 2005;5:287-95.
25. Björntorp P. "Portal" adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Arteriosclerosis. 1990;10:493-6.
26. Mohamed-Ali V, Pinkney JH, Coppack SW. Adipose tissue as an endocrine and paracrine organ. Int J Obes Relat Metab Disord. 1998;22:1145-58.
27. Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev. 2000; 21:697-738.
28. Hickman U, Jonsson JR, Prins JB, et al. Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life. Gut. 2004;53:413-9.
29. Tiikkainen M, Bergholm R, Vehkavaara S, et al. Effects of identical weight loss on body composition and features of insulin resistance in obese women with high and low liver fat content. Diabetes. 2003;52:701-7.
30. Bajaj M, Suraamornkul S, Piper P, et al. Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients. J Clin Endocrinol Metab. 2004;89:200-6.
31. Ross R, Janssen I, Dawson J, et al. Exercise-induced reduction in obesity and insulin resistance in women: a randomized controlled trial. Obes Res. 2004;12:789-98.
32. Janssen I, Ross R. Effects of sex on the change in visceral, subcutaneous adipose tissue and skeletal muscle in response to weight loss. Int J Obes Relat Metab Disord. 1999;23:1035-46.
33. Ross R, Rissanen J, Hudson R. Sensitivity associated with the identification of visceral adipose tissue levels using waist circumference in men and women: effects of weight loss. Int J Obes Relat Metab Disord. 1996;20:533-8.
34. Pare A, Dumont M, Lemieux I, et al. Is the relationship between adipose tissue and waist girth altered by weight loss in obese men? Obes Res. 2001;9:526-34.
35. Blair SN, Goodyear NN, Gibbons LW, Cooper KH. Physical fitness and incidence of hypertension in healthy normotensive men and women. JAMA. 1984;252:487-90.